- Is Cancer Genomics Consortium a tax-exempt 501(c)(3)?
- Yes. Cancer Genomics Consortium is recognised by the IRS as a 501(c)(3) organisation (EIN 27-3232063). The IRS recognised Cancer Genomics Consortium as tax-exempt in March 2014.
- What is Cancer Genomics Consortium's EIN?
- Cancer Genomics Consortium's Employer Identification Number (EIN) is 27-3232063. The EIN was assigned by the IRS in March 2014. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Cancer Genomics Consortium do?
- The Cancer Genomics Consortium (CGC) is committed to providing high quality education and promoting best laboratory practices in clinical Cancer Genomics.
- Where is Cancer Genomics Consortium located?
- Cancer Genomics Consortium is located at 32 White Pine Circle, Fletcher, NC, 28732.
- When was Cancer Genomics Consortium founded or recognised by the IRS?
- Cancer Genomics Consortium was recognised by the IRS as a tax-exempt organisation in March 2014. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Cancer Genomics Consortium's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Cancer Genomics Consortium reported $512K in total revenue and $498K in total expenses.
- Has Cancer Genomics Consortium been auto-revoked by the IRS?
- No. Cancer Genomics Consortium (EIN 27-3232063) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Cancer Genomics Consortium listed in IRS Publication 78?
- Yes. Cancer Genomics Consortium is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
